Sitamaquine
Alternative Names: Q45; WR 006026; WR 6026Latest Information Update: 05 Nov 2023
At a glance
- Originator Walter Reed Army Institute of Research
- Class Antiprotozoals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Babesiosis; Visceral leishmaniasis
Most Recent Events
- 03 Sep 2005 This compound is still in active development for Visceral leishmaniasis
- 11 May 2004 No development reported - Preclinical for Babesiosis in USA (unspecified route)
- 31 Dec 2003 Phase-II clinical trials in Visceral leishmaniasis in India (PO)